Dietary agents in prevention of prostate cancer

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 2, 2008, Pages 183-186

  Süral, Yavuz Selim ^a   Sari, Dilek ^b   Turgay, Aye San ^b   Turan, Dilek ^a  

^a Medical Oncology Clinic Izmir Tepecik Training and Research Hospital   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Chemoprevention; Dietary agents; Prostate cancer

Indexed keywords

DIET THERAPY; HUMAN; MALE; PROSTATE TUMOR; REVIEW;

HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 59849128198     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Adhami VM, Siddiqui IA, Ahmad N, et al, (2004). Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res, 64, 8715-22.
2. Clark LC, Dalkin B, Krongrad A, et al, (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81, 730-4.
3. Giovannucci E (1999). Tomatoes, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst, 91, 317-31.
4. Goodman GE, Schaffer S, Omenn GS, et al, (2003). The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev, 12, 518-26.
5. Greenwald P (2004). Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr, 134, 3507S-12S.
6. Gronberg H (2003). Prostate cancer epidemiology. Lancet, 361, 859-64.
7. Gupta S (2007). Prostate cancer chemoprevention: current status and future prospects. Toxicol Appl Pharmacol, 224, 369-76.
8. Hartman TJ, Dorgan JF, Virtamo J, et al, (1999). Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cancer, 35, 10-5.
9. Hedlund TE, Johannes WU, Miller GJ, (2003). Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate, 54, 68-78.
10. Heinonen OP, Albanes D, Virtamo J, et al, (1998). Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90, 440-6.
11. Jacobsen BK, Knutsen SF, Fraser GE (1998). Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control, 9, 553-7.
12. Kelloff GJ, Lieberman R, Steele VE, et al (1999). Chemoprevention of prostate cancer: concepts and strategies. Eur Urol, 35, 342-50.
13. Khuri FR, Sabichi AL, Hong WK, et al, (1999). The chemoprevention of cancer. In: Pollock RE, editor. Manual of Clinical Oncology. New York: Wiley-Liss Inc., 163-9.
14. Kirsh VA, Mayne ST, Peters U, et al, (2006). A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 92-8.
15. Klein EA (2005). Chemopreventon of prostate cancer. Crit Rev Oncol Hematol, 54, 1-10.
16. Klein EA, Lippman SM, Thompson IM, et al, (2003). The selenium and vitamin E cancer prevention trial. World J Urol, 21, 21-7.
17. Klein EA, Thompson IM (2004). Update on chemoprevention of prostate cancer. Curr Opin Urol, 14, 143-9.
18. McCall MR, Frei B (1999). Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med, 26, 1034-53.
19. Mohanty NK, Saxena S, Singh UP, et al, (2005). Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol, 23, 383-5.
20. Obermuller-Jevic UC, Olano-Martin E, Corbacho AM, et al, (2003). Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nut, 133, 3356-60.
21. Parkin DM, Bray F, Ferlay J, et al, (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
22. Rodriguez C, Jacobs EJ, Mondul AM, et al, (2004). Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev, 13, 378-382.
23. Siler U, Barella L, Spitzer V, et al, (2004). Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J, 18, 1019-21.
24. Williams CA, Grayer RJ (2004). Anthocyanins and other flavonoids. Nat Prod Rep, 21, 539-73.
25. Saleem M, Adhami VM, Siddiqui IA et al, (2003). Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer, 47, 13-23.
26. Shukla S, Gupta S (2005). Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer, 53, 18-32.
27. Yu L, Blackburn GL, Zhou JR (2003). Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells. J Nutr, 133, 389-92.
28. The SELECT Prostate Cancer Prevention Trial [Online]. National Cancer Institute. http://www.nci.nih.gov/select (accessed July 17, 2004).